The nurse provides teaching for patient who will begin taking montelukast sodium (Singulair). Which statement by the patient indicates a need for further teaching?

A. "I will use this as needed for acute symptoms.": Montelukast is not a rescue medication and should not be used for acute asthma attacks. It is a leukotriene receptor antagonist intended for daily maintenance therapy to prevent bronchoconstriction. Using it for sudden symptoms could delay appropriate treatment. B. "I will need to have periodic laboratory tests while taking this medication.": Routine lab monitoring is generally not required for montelukast, as it does not significantly affect kidney, liver, or blood parameters in most patients. Ordering unnecessary labs indicates a misunderstanding of the medication’s safety profile. C. “I will take one tablet daily at bedtime.": This statement demonstrates correct understanding, as montelukast is taken once daily, typically in the evening, to provide optimal control of nocturnal symptoms. D. "I will begin participating in a smoking cessation program at work.": Engaging in smoking cessation is appropriate and beneficial for respiratory health, complementing asthma management and montelukast therapy.